Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
ConvaTec ( (GB:CTEC) ) just unveiled an announcement.
ConvaTec reported a solid start to 2026, with year-to-date organic revenue growth of 4.8% excluding InnovaMatrix and broad-based gains across all major categories, supported by successful product launches such as ConvaFoam, Esteem Body and GentleCath Air. The company reiterated its full-year guidance for 5–7% organic revenue growth excluding InnovaMatrix, at least a 23% adjusted operating margin and double-digit adjusted EPS growth, while highlighting increased growth capex, a deepening innovation pipeline, a new patch pump supply deal in infusion care and its “Accelerate” strategy aimed at sustaining 6–8% annual revenue growth from 2027, reinforcing its competitive position in chronic care markets.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on CTEC Stock
According to Spark, TipRanks’ AI Analyst, CTEC is a Neutral.
The score is driven primarily by solid underlying financial performance (growth, improving operating margins, positive free cash flow) and supportive guidance for continued growth and margin expansion. This is tempered by increased leverage and notable operational/regulatory risks flagged on the call, while valuation looks expensive and technicals appear near overbought despite an uptrend.
To see Spark’s full report on CTEC stock, click here.
More about ConvaTec
ConvaTec Group is a global medical products and technologies company focused on chronic condition management, with leading positions in advanced wound care, ostomy care, continence care and infusion care. The FTSE 100-listed group generates over $2 billion in annual revenue and sells products and services in around 90 countries, aiming to improve patient outcomes and lower care costs.
Average Trading Volume: 11,267,112
Technical Sentiment Signal: Sell
Current Market Cap: £4.18B
For an in-depth examination of CTEC stock, go to TipRanks’ Overview page.